Skip to main content

Advertisement

Table 1 Clinical and laboratory characteristics of the CLL patients evaluated using methylation and gene expression arrays

From: Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia

Characteristics of the patients
Sr. No Sample ID Methylation array GE array Rai stage Age Tumor Percentage IGHV status β2M(mg/L) 17p Deletion IPI Score
1 S1   0 41 67.2 UM 6.56 Absent 4
2 S2 0 63 69 UM 4.06 Absent 4
3 S3 0 69 88.6 UM 8.42 Absent 5
4 S4 I 45 95.4 UM 4.6 Present 9
5 S5 I 60 93.5 UM 3.37 Absent 3
6 S6 II 50 66 UM 4.78 Absent 5
7 S7   II 59 97.2 M 3.54 Absent 3
8 S8   0 57 95.3 M 6.49 Absent 2
9 S9   II 65 92.8 M 4.58 Absent 3
10 S10 0 61 69.3 M 3.3 Absent 0
11 S11 II 65 97.2 M 4.48 Present 7
12 S12 II 67 98 UM 5.69 Absent 6
13 S13 II 48 92 UM 4.42 Absent 5
14 S14   I 58 95.62 UM 6.31 Absent 5
15 S15   I 46 79.4 UM 6.78 Absent 5
16 S16   II 59 73 UM 4.43 Absent 5
17 S17   I 40 90 UM 7.74 Absent 5
18 S18   I 67 79.3 UM 2.59 Absent 4
19 S19   I 51 80 M 5.44 Absent 3
20 S20   0 57 72.5 M 2.91 Absent 0
21 S21   II 65 68.6 M 7.1 Absent 2
22 S22   II 52 66 M 3.2 Absent 1
23 S23   I 60 92 M 6.56 Absent 3
24 S24   I 44 85.1 M 3.62 Absent 3
25 S25   II 68 93 M 6.47 Absent 4
26 S26   II 80 68.4 M 6.46 Absent 4
  1. Abbreviations used: GE Gene expression, UM Unmutated, M Mutated , β 2 M Beta 2 Microglobulin, IPI International Prognostic index